Home›Stock Screener›Bilcare

Bilcare Share Price Today | Stock Price & Bilcare Share Screener

BI Healthcare Technology
Live Share Price NSE
₹101.38
▲ 9.21 (9.99%)
2026-08-18 00:00:00
Live Share Price BSE
₹94.77
▼ -1.93 (-2.00%)
2026-10-05 00:00:00

As of August 18, 2026, the live Bilcare share price (NSE: BI) is ₹101.38 on NSE and ₹94.77 on BSE, up 9.99% from the previous close, with shares trading between ₹92.17 and ₹101.38 in today's trading session, and a 52-week range of ₹56.18–₹101.38. Check BI 52-week performance for the annual price range and momentum. Use the Bilcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Bilcare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹228 and net income of ₹15, with EBITDA of ₹37, an operating margin of 16.0% and a profit margin of 6.6%.

Bilcare Market Cap ₹227.68 Cr.
BI P/E Ratio (TTM) -35.68
Bilcare P/B Ratio 1.16
EPS (TTM) ₹0.73
Dividend Yield -
Debt to Equity 3.19
BI 52 Week High ₹101.38
Bilcare 52 Week Low ₹56.18
Operating Margin 16.00%
Profit Margin 6.58%
BI Revenue (TTM) ₹228.00
EBITDA ₹37.00
Net Income ₹15.00
Total Assets ₹843.00
Total Equity ₹74.00

Bilcare Share Price Chart

Track the current stock price of Bilcare with an interactive chart. Analyse BI share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Bilcare stock quote in one place.

The quote of ₹101.38 sits between the 52-week low of ₹56.18 and the 52-week high of ₹101.38, and the latest session moved 9.99% from the previous close.

Bilcare Company Profile - Fundamental Screener

Screen Bilcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BI shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Technology industry, and it trades under ISIN INE986A01012.

Company Details

Classification

Sector Healthcare
Industry Healthcare Technology
Sub-Sector Healthcare Technology
Segment E

Identifiers and Leadership

ISIN INE986A01012

Bilcare Balance Sheet Screener

Screen BI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹843, down from ₹924 in 2025.

Latest statistics put total assets at ₹843 and shareholder funds at ₹74, with a leverage ratio of 3.19.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 843 924 1,568 1,593 1,127 1,064 1,112 3,159 3,479 3,507
Current Assets 353 343 411 343 421 337 365 882 933 788
Fixed Assets 432 456 1,038 1,046 465 494 534 2,006 2,180 2,403

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 477 495 572 551 563 586 624 1,096 1,037 2,085
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 74 90 646 704 161 164 176 -6 463 676
Share Capital 24 24 24 24 24 24 24 24 24 24
Reserves & Surplus 173 191 474 507 52 63 85 -93 376 590

Bilcare Income Statement Screener - Profit & Revenue Analysis

Screen Bilcare income statement and profit fundamentals. Analyze BI quarterly results. Bilcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹228 and net profit was ₹15, equal to earnings per unit of ₹5.39, at an operating margin of 16%.

In that period expenses were ₹191, interest cost ₹18 and tax ₹0. The next period listed, 2026-Mar, shows revenue of ₹202 and net profit of ₹8.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar

Revenue and Expenses

Revenue 228 202 187 183 192 215 202 206 198 198 209 179 200 186 465
Expenses 191 173 170 175 175 186 197 204 175 175 208 158 183 170 219

Operating Costs and Margins

EBITDA 37 29 16 8 17 29 4 2 23 23 1 21 17 16 246
Operating Profit % 16.00% 8.00% 6.00% 2.00% 6.00% 4.00% 0.00% -1.00% 10.00% 10.00% -4.00% 10.00% 4.00% 7.00% 6.00%
Depreciation 4 5 5 12 12 5 12 11 12 12 13 11 11 11 9
Interest 18 18 17 19 19 19 20 24 21 21 23 21 20 19 11

Profit and Earnings

Profit Before Tax 15 7 -6 -24 -13 6 -27 -33 -10 -10 -35 -10 -13 -13 225
Tax 0 -1 0 0 -3 -7 -11 -3 5 5 -16 3 -1 0 147
Net Profit 15 8 -6 -23 -10 12 -16 -30 -15 -15 -20 -14 -12 -13 78
EPS 5.39 5.68 0.41 -5.25 -1.61 7.47 -3.05 -6.81 -2.71 -2.71 -4.63 -2.91 -3.22 -3.36 19.63

Bilcare Cash Flow Screener - Liquidity Fundamentals

Screen BI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹128, and net cash flow was an outflow of ₹10.

Over the same period, investing activities used ₹5 and financing activities used ₹132.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 128 86 63 -7 41 72 256 206 99 300
Investing Activities -5 81 -106 36 -4 2 1,309 -104 -203 -129

Financing and Net Cash

Financing Activities -132 -171 36 -19 -55 -83 -1,600 -103 91 -155
Net Cash Flow -10 -3 -8 10 -18 -9 -35 -1 -13 16

Bilcare Shareholding Pattern Screener

See Bilcare shareholding pattern with promoter, FII, and DII holdings. Check Bilcare promoter holding and ownership changes for BI on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 30.01%, foreign institutions 0.04%, domestic institutions 0.00% and the public 45.32%, spread across 15,777 shareholders.

The shareholder count was 15,777 in 2026-Jun, compared with 15,824 in 2026-Mar.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept

Promoter Holding

Promoter Holding 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01%

Institutional Investors

FII Holding 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 45.32% 45.18% 45.45% 45.40% 44.96% 44.68% 45.40% 45.51%
Other Holding 24.62% 24.76% 24.49% 24.54% 24.99% 25.26% 24.55% 24.43%
Shareholder Count 15,777 15,824 16,068 16,513 17,047 17,586 18,496 18,241

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Bilcare. Bilcare dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Bilcare.

Bilcare Stock Index Membership - Nifty & Sensex

See which indices include Bilcare stock. Check BI index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Bilcare is not part of any tracked indices.
Only major market indices are tracked in our system.

Bilcare Market Events Screener - Corporate Actions

Get Bilcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Bilcare stock events that may affect BI share price, along with derivatives, futures and options activity and sector gainers.

11 corporate actions are listed, the most recent entry being Annual General Meeting dated September 26, 2026, with a record date of September 26, 2026.

It is followed by Quarterly Result Announcement dated August 13, 2026 and Quarterly Result Announcement dated May 29, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-26 2026-09-26 Annual General Meeting NA 14.35%
2026-08-13 2026-08-13 Quarterly Result Announcement NA 5.28%
2026-05-29 2026-05-29 Quarterly Result Announcement NA -1.29%
2026-02-12 2026-02-12 Quarterly Result Announcement NA 2.30%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -5.12%
2025-09-24 2025-09-24 Annual General Meeting NA 31.15%
2025-08-14 2025-08-14 Quarterly Result Announcement NA -1.45%
2025-05-28 2025-05-28 Quarterly Result Announcement NA -0.20%
2025-02-13 2025-02-13 Quarterly Result Announcement NA -13.94%
2024-11-13 2024-11-13 Quarterly Result Announcement NA -5.03%
2024-09-27 2024-09-27 Annual General Meeting NA -7.47%

Bilcare Competitors Screener - Peer Stocks Comparison

Screen BI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 9 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Syngene International 14,498 65.99 3,809 2.56% 317 31.20
Indegene 14,434 35.70 3,583 21.58% 401 53.26
Suven Life Sciences 8,641 -24.74 21 19.32% -276 34.07
Vimta Labs 2,627 35.09 322 0.22% 41 39.40
Bilcare 228 -35.68 764 -5.33% -17 51.60
TAKE 182 14.49 61 497.06% 4 27.68
Jeevan Scientific Technology 171 33.22 62 29.56% 2 62.97
Adeshwar Meditex 24 33.09 56 -33.10% 1 53.57
Vanta Bioscience 15 143.27 2 -13.33% 0 48.79

Bilcare Company Announcements - News & Reports Screener

Screen BI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 1, 2026.

The next most recent announcements are dated September 30, 2026 and September 28, 2026.

Date Update Actions
2026-10-01 Voting Results Of 39Th Annual General Meeting And Scrutinizers Report -
2026-09-30 Closure of Trading Window -
2026-09-28 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-26 Corrigendum To Notice Of The 39Th Annual General Meeting -
2026-09-26 Corrigendum To Notice Of The 39Th Annual General Meeting -
2026-09-21 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-09-07 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-04 Board Meeting Outcome for Outcome Of Board Meeting -
2026-09-04 Reg. 34 (1) Annual Report. -
2026-09-04 Annual Report - 2025-26 -
2026-08-22 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-08-15 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-13 Voluntary Winding Up Of Wholly Owned Subsidiary -
2026-08-13 Appointment of Company Secretary and Compliance Officer -
2026-08-13 Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer -
2026-08-13 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-13 Standalone & Consolidated Unaudited Financial Results For The Quarter Ended On 30 June 2026 Along With Limited Review Report Issued By Statutory Auditors Of The Company -
2026-08-13 Board Meeting Outcome for Outcome Of Board Meeting -
2026-08-07 Board Meeting Intimation for Considering Standalone & Consolidated Unaudited Financial Results For The Quarter Ended On 30 June 2026 -
2026-07-24 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹101.38, within a 52-week range of ₹56.18 to ₹101.38. The P/E ratio is -35.68 and the P/B ratio is 1.16, with earnings per unit of ₹0.73. Market capitalisation stands at ₹227.68 Cr. The company operates in the Healthcare sector, in the Healthcare Technology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.